Clinical Trials in Groningen, Netherlands
7 recruiting
Showing 1–18 of 18 trials
Recruiting
Phase 3
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
Triple Negative Breast Neoplasms
Merck Sharp & Dohme LLC1,000 enrolled250 locationsNCT06841354
Recruiting
Spectral Cancer Tissue Recognition - I
Breast CancerMargin Assessment
SPCTR100 enrolled2 locationsNCT07459062
Recruiting
Phase 3
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Non-small Cell Lung Cancer
AstraZeneca880 enrolled300 locationsNCT06692738
Recruiting
Phase 3
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
AstraZeneca4,300 enrolled727 locationsNCT05774951
Recruiting
Phase 2
A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02)
Recurrent or Metastatic Solid Tumors
Daiichi Sankyo520 enrolled119 locationsNCT06330064
Recruiting
Phase 2
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Breast CancerEsophageal CancerGastric Cancer+11 more
Daiichi Sankyo740 enrolled84 locationsNCT06172478
Recruiting
Phase 2
A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors
Part 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal CancerPart 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal Cancer
AstraZeneca468 enrolled123 locationsNCT04482309
Recruiting
Early Phase 1
PET-imaging of Two Vartumabs in Patients With Solid Tumors
Breast CancerBladder CarcinomaEsophageal Carcinoma+11 more
Var2 Pharmaceuticals32 enrolled1 locationNCT06645808
Recruiting
TAO-Towards Optimal (Neo)Adjuvant Systemic Therapy of Stage III Triple-negative Breast Cancer
Breast Cancer
The Netherlands Cancer Institute100 enrolled6 locationsNCT06931769
Recruiting
Not Applicable
The TASTY-steering Study
Metastatic Triple Negative Breast Cancer or Metastatic Testicular Cancer, or Stage II-IV Diffuse Large B Cell Lymphoma
University Medical Center Groningen201 enrolled11 locationsNCT07258563
Recruiting
Early Ageing During Therapy in AYA Cancer Patients
Breast CancerCervical CancerCancer+5 more
University Medical Center Groningen120 enrolled1 locationNCT05062707
Recruiting
Phase 1Phase 2
Study of DF1001 in Patients with Advanced Solid Tumors
Solid Tumor, Adult
Dragonfly Therapeutics378 enrolled52 locationsNCT04143711
Recruiting
Phase 2
FUnctional Selection of Advanced Breast Cancer Patients for Talazoparib Treatment Using the REpair Capacity (RECAP) Test
Advanced Breast Cancer
Erasmus Medical Center66 enrolled3 locationsNCT06193525
Recruiting
Phase 2
COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in Metastatic Breast Cancer - the COSMO Study
Breast Cancer InvasiveMetastatic CancerOligoprogressive
The Netherlands Cancer Institute118 enrolled7 locationsNCT05301881
Recruiting
Not Applicable
Comparison of Low-dose Spiral Breast CT With MRI in Major Indications of MRI for Breast Diagnostics
Breast Cancer Diagnosis
AB-CT - Advanced Breast-CT GmbH428 enrolled4 locationsNCT05989022
Recruiting
Breast Cancer Long-term Outcomes on Cardiac Functioning: a Longitudinal Study
Heart FailureCardiotoxicityNeoplasm, Breast+1 more
University Medical Center Groningen455 enrolled1 locationNCT05851053
Recruiting
Not Applicable
Fluorescence Guided Surgery in Breast Cancer - The MARGIN-2 Study
Breast CancerBreast Cancer Invasive
University Medical Center Groningen70 enrolled2 locationsNCT05939310
Recruiting
Minimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast Cancer
Breast CancerNeoadjuvant TherapyLymph Node Metastases
Maastricht University Medical Center549 enrolled35 locationsNCT04486495